pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 15·1 min read
save

NIH now allows businesses to apply for its research funding

Sep 15, 2026·read at STAT ↗RegulatoryPositive

The National Institutes of Health announced that companies are eligible to submit grant applications, expanding the pool of potential research partners. This change aims to foster collaboration between the public sector and private industry in advancing biomedical science.

The update was highlighted in STAT’s Morning Rounds newsletter, which also featured a poll on public trust in science, a discussion about protecting heart health during space travel, and a note about RFK Jr.’s upcoming talk at a Children’s Health Defense event.

The newsletter, edited by Amanda Erickson, is published twice weekly and invites reader feedback on its content and format.

The policy shift could open new financing avenues for biotech firms seeking NIH support, potentially accelerating drug development and innovation.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Businesses can now apply for NIH funding”

read at STAT ↗
1,567 words · retrieved Sep 15
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING3National Institutes of Health2RISING2HERITAGE
drugs
Obesity
topics
Cardiology12Endocrinology & Metabolism2Hematology2Oncology2Type 2 Diabetes2Vaccines2HypertensionObesityOphthalmologyVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • Aug 11Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsSTAT
  • Jul 15Deaths from coronary artery disease have fallen, but more progress is within reachSTAT
  • 6d agoHealth insurance premiums jump 9%, and more Americans don’t have access to coverageSTAT